Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Benson

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
AIDS Research and Human Retroviruses|February 15, 2001
In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12)J M Young, R A Ffrench, J D Clarkson, et al.
AIDS Research and Human Retroviruses|February 24, 1999
Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individualsE M Benson, J Clarkson, M Law, et al.
Journal of Virology|December 1, 1996
Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virusB M Kerr, N Kienzle, J M Burrows, et al.
AIDS (London, England)|December 31, 1997
Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study GroupG J Stewart, L J Ashton, R A Biti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoterJ T Kurnick, T Ramirez-Montagut, L A Boyle, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
AIDS Research and Human Retroviruses|February 15, 2001
In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12)J M Young, R A Ffrench, J D Clarkson, et al.
AIDS Research and Human Retroviruses|February 24, 1999
Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individualsE M Benson, J Clarkson, M Law, et al.
Journal of Virology|December 1, 1996
Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virusB M Kerr, N Kienzle, J M Burrows, et al.
AIDS (London, England)|December 31, 1997
Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study GroupG J Stewart, L J Ashton, R A Biti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoterJ T Kurnick, T Ramirez-Montagut, L A Boyle, et al.
Pageof 3